Browsing by Author "Gil-Gil, Miguel J."
Now showing items 1-3 of 3
-
Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study
Gil-Gil, Miguel J.; Bergamino, Milana; Morales, Serafin; Barnadas, Agustí; Manso, Luis; Bellet Ezquerra, Meritxell; Saura Manich, Cristina (Frontiers Media, 2021-07) -
Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial
Albanell, Joan; Pérez-García, José Manuel; Gil-Gil, Miguel J.; Ruiz Borrego, Manuel; Comerma Blesa, Laura; Bellet Ezquerra, Meritxell; Curigliano, Giuseppe (American Association for Cancer Research, 2023-01-04) -
Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial
Pérez-García, José Manuel; Dalenc, Florence; Gil-Gil, Miguel J.; Ruiz Borrego, Manuel; Di Cosimo, Serena; Bellet Ezquerra, Meritxell (Oxford University Press, 2023-01)